Blueprint Medicines Corporation (BPMC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 5.48B |
| Enterprise Value | 5.85B |
| P/E Ratio | -166.47 |
| PEG Ratio | 0.8 |
| Price/Sales Ratio | 28.27 |
| Price/Book Ratio | 24.07 |
| Enterprise/Revenue | 28.27 |
| Enterprise/EBITDA | -122.6 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
| Profit Margin | -0.17 |
| Operating Margin | -0.28 |
| Return On Assets | -0.04 |
| Return On Equity | -0.15 |
| Revenue | 508.82M |
| Revenue/Share | 4.65 |
| Gross Profit | 488.66M |
| EBITDA | 19.23M |
| Net Income | -67.09M |
| Diluted EPS | -1.07 |
| Total Cash | 576.24M |
| Total Cash/Share | 9.06 |
| Total Debt | 122.75M |
| Total Debt/Equity | 0.36 |
| Current Ratio | 2.8 |
| Book Value Per Share | 5.38 |
| 52-Week Change | 35.28 |
| 52-Week High | 129.55 |
| 52-Week Low | 73.04 |
| Moving Average 50 Days | 116.52 |
| Moving Average 200 Days | 98.82 |
| Average Volume | 3.29M |
| Shares Outstanding | 64.58M |
| % Held by Institutions | 101.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |